Daliresp

Daliresp is an oral medication specifically designed to reduce the risk of exacerbations in patients with severe chronic obstructive pulmonary disease (COPD) associated with chronic bronchitis and a history of exacerbations. It works by targeting inflammation in the lungs, a key factor in COPD progression. Daliresp offers a valuable treatment option for managing persistent symptoms and improving lung function in suitable patients. This medication helps to maintain respiratory health and reduce the frequency of acute flare-ups.

Delivery: 5–21 days (depending on the shipping method selected)
Extra 10% off with code: EXTRA10

Each dosage option has its own packaging variants.

Category: Active Ingredient: Roflumilast